JPMorgan Chase does not report until Tuesday, October 13, but the setup for that morning is already clearer than the market seems to be pricing. The bank enters the quarter having just delivered one of the strongest results in its history, and management’s own guidance suggested the momentum was continuing rather than reversing.

The Business

JPMorgan is the largest bank in the United States by assets, and by this point its earnings report functions as a proxy for the health of global capital markets, corporate credit, and consumer spending simultaneously. That breadth is the product, not a liability. When dealmaking accelerates, equity trading surges, and loan demand holds, JPMorgan benefits from all three at once. The second quarter showed exactly that.

Why Wall Street Is Paying Attention

The Q2 results were exceptional by any measure. JPMorgan reported $21.2 billion in net income, $7.70 in EPS, $58.0 billion in managed revenue, a 29% return on tangible common equity, and a 14.1% standardized Common Equity Tier 1 capital ratio. Revenue came in well ahead of consensus. The bank then raised guidance: full-year net interest income excluding markets is now expected near $96.5 billion, with total NII near $105.5 billion.

What matters for October 13 is whether that momentum continued. Management said it did. Co-President Doug Petno guided for investment banking fees and markets revenue to rise in the mid-to-high-teens percentage in Q3. That guidance was issued on September 15, well into the quarter, which makes it more than a forecast. It is a read. Petno described a strong pipeline and broad-based strength, particularly in M&A, as boards showed greater confidence in pursuing transactions.

What’s Driving the Opportunity

The first half of 2026 told a consistent story. Investment banking fees were up 29% year-over-year, driven by higher fees across products. The firm also highlighted a number one ranking for global investment banking fees year-to-date through June 30, according to Dealogic. Equity markets revenue was sharply higher in Q2, driven by strength across products.

The bank’s previous quarter exceeded expectations, with EPS of $6.14 excluding significant items. Consensus for Q3 now sits at roughly $5.90 per share on $51.2 billion in revenue, a meaningful step down sequentially, but one driven by the unusually strong base rather than any deterioration in the business.

The bank also has said it has approximately $40 billion in excess capital, with a preference for organic growth and selective buybacks, leaving the door open to value-accretive acquisitions. The quarterly dividend has been raised to $1.65 per share, equivalent to $6.60 annually.

What Could Go Wrong

The bar is genuinely high. Options markets are pricing roughly a 4.3% earnings-day move, above JPMorgan’s 10-year average peak earnings-day move of about 3.4%. That spread reflects real uncertainty about whether Q2 was a ceiling or a floor.

Rising credit costs remain the main downside risk, alongside the question of whether resilient net interest income and deal activity can hold into Q3. Rising non-interest expenses are also a primary operational risk. A quarter where revenues beat but expenses overshoot would not be warmly received at current prices.

The Bottom Line

JPM closed at $332.38 on October 5, with a market capitalization near $888 billion. That puts the stock roughly 9% below its 52-week high of $366.50, trading at a forward multiple that does not look stretched given the earnings pace. Management expects mid- to high-teens percentage year-over-year growth in investment banking fees and markets revenue, and the deal environment, from what the bank itself has said publicly, appears to support that. Five days from now, the market gets its answer.